recombinant vaccinia-TRICOM vaccine

BIOLOGICAL4 trials

Sponsors

Herbert Irving Comprehensive Cancer Center, National Cancer Institute (NCI)

Conditions

Male Breast CancerMelanoma (Skin)Prostate CancerRecurrent Breast CancerRecurrent Prostate CarcinomaStage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer

Phase 1

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Herbert Irving Comprehensive Cancer CenterMelanoma (Skin)

Start: 2001-08-31Updated: 2013-12-18

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

TerminatedNCT00071942

National Cancer Institute (NCI)Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer

Start: 2003-10-31Target: 22Updated: 2013-12-11

Phase 2

A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer

CompletedNCT00108732

National Cancer Institute (NCI)Recurrent Prostate Carcinoma, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer +2

Start: 2006-02-28End: 2010-10-31Updated: 2015-06-30

153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer

CompletedNCT00450619

National Cancer Institute (NCI)Prostate Cancer

Start: 2007-02-28End: 2012-11-30Updated: 2017-01-04